Ovintiv financials
$58.83−1.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $8.91B | $9.15B | $10.88B | $14.33B | $10.54B | $5.58B |
| Gross profit | $6.60B | $6.67B | $7.21B | $10.28B | $7.59B | $3.61B |
| Gross margin | 74.1% | 72.9% | 66.2% | 71.7% | 72.0% | 64.7% |
| Operating income | $1.13B | $1.58B | $2.86B | $5.72B | $3.40B | -$5.90B |
| Net income | $1.24B | $1.13B | $2.08B | $3.64B | $1.42B | -$6.10B |
| Net margin | 13.9% | 12.3% | 19.2% | 25.4% | 13.4% | −109.3% |
| Diluted EPS | $4.78 | $4.21 | $7.90 | $14.08 | $5.32 | $-23.47 |
| EBITDA | $4.23B | $4.32B | $4.69B | $6.83B | $4.59B | $1.51B |
| Operating cash flow | $3.65B | $3.72B | $4.17B | $3.87B | $3.13B | $1.90B |
| Free cash flow | -$1.03B | $1.21B | $1.15B | $1.75B | $1.60B | $159.0M |
| Diluted shares | 259.7M | 267.4M | 263.9M | 258.4M | 266.4M | 259.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.0M | $42.0M | $3.0M | $5.0M | $195.0M | $10.0M |
| Short-term investments | $245.0M | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $5.20B | $5.45B | $5.74B | $3.57B | $4.79B | $6.88B |
| Total assets | $20.39B | $19.25B | $19.99B | $15.06B | $14.05B | $14.47B |
| Total liabilities | $9.20B | $8.92B | $9.62B | $7.37B | $8.98B | $10.63B |
| Shareholders' equity | $11.20B | $10.33B | $10.37B | $7.69B | $5.07B | $3.84B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology